1. Home
  2. SRPT vs GWRE Comparison

SRPT vs GWRE Comparison

Compare SRPT & GWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • GWRE
  • Stock Information
  • Founded
  • SRPT 1980
  • GWRE 2001
  • Country
  • SRPT United States
  • GWRE United States
  • Employees
  • SRPT N/A
  • GWRE N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • GWRE Computer Software: Prepackaged Software
  • Sector
  • SRPT Health Care
  • GWRE Technology
  • Exchange
  • SRPT Nasdaq
  • GWRE Nasdaq
  • Market Cap
  • SRPT 12.2B
  • GWRE 11.5B
  • IPO Year
  • SRPT 1997
  • GWRE 2012
  • Fundamental
  • Price
  • SRPT $104.54
  • GWRE $192.22
  • Analyst Decision
  • SRPT Strong Buy
  • GWRE Buy
  • Analyst Count
  • SRPT 21
  • GWRE 15
  • Target Price
  • SRPT $182.00
  • GWRE $175.00
  • AVG Volume (30 Days)
  • SRPT 1.0M
  • GWRE 694.0K
  • Earning Date
  • SRPT 11-06-2024
  • GWRE 12-05-2024
  • Dividend Yield
  • SRPT N/A
  • GWRE N/A
  • EPS Growth
  • SRPT N/A
  • GWRE N/A
  • EPS
  • SRPT 1.22
  • GWRE N/A
  • Revenue
  • SRPT $1,640,348,000.00
  • GWRE $980,497,000.00
  • Revenue This Year
  • SRPT $45.98
  • GWRE $18.61
  • Revenue Next Year
  • SRPT $78.13
  • GWRE $14.62
  • P/E Ratio
  • SRPT $85.70
  • GWRE N/A
  • Revenue Growth
  • SRPT 48.45
  • GWRE 8.30
  • 52 Week Low
  • SRPT $78.67
  • GWRE $95.02
  • 52 Week High
  • SRPT $173.25
  • GWRE $199.33
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 23.65
  • GWRE 59.43
  • Support Level
  • SRPT $116.32
  • GWRE $194.31
  • Resistance Level
  • SRPT $122.63
  • GWRE $199.33
  • Average True Range (ATR)
  • SRPT 4.97
  • GWRE 2.76
  • MACD
  • SRPT -2.19
  • GWRE -0.12
  • Stochastic Oscillator
  • SRPT 6.47
  • GWRE 51.89

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

About GWRE Guidewire Software Inc.

Guidewire Software provides software solutions for property and casualty insurers. Flagship product InsuranceSuite is an on-premises system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a cloud-based offering, as well as a variety of other add-on applications.

Share on Social Networks: